טוען...
Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel
BACKGROUND: Chemotherapy with praziquantel (PZQ) is the mainstay of schistosomiasis control. However, there are recent concerns about tolerance or resistance to PZQ, so that monitoring its efficacy in different settings is required. METHODS: A longitudinal study was conducted to evaluate the impact...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3434009/ https://ncbi.nlm.nih.gov/pubmed/22676052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-3305-5-108 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|